STOCK TITAN

Oric Pharmaceuticals: EcoR1 reports 2.9% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Oric Pharmaceuticals, Inc. (ORIC) common stock is the subject of an amended ownership report by EcoR1 Capital, LLC, Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. EcoR1 and Nodelman each reported beneficial ownership of 3,028,116 shares (2.9%); Qualified Fund reported 2,885,435 shares (2.8%). Each reported shared voting and dispositive power over its stated amount and zero sole voting or dispositive power. EcoR1 is the general partner and investment adviser of funds including Qualified Fund, and Nodelman is EcoR1’s control person. The reporting persons stated they filed jointly, not as a group, and disclaimed beneficial ownership except to the extent of each person’s pecuniary interest.
Beneficial ownership — EcoR1 Capital, LLC 3,028,116 shares Reported as 2.9% of the class.
Beneficial ownership — Oleg Nodelman 3,028,116 shares Reported as 2.9% of the class.
Beneficial ownership — EcoR1 Capital Fund Qualified, L.P. 2,885,435 shares Reported as 2.8% of the class.
Ownership percentage — EcoR1 Capital, LLC 2.9% Percentage of the class reported.
Ownership percentage — Oleg Nodelman 2.9% Percentage of the class reported.
Ownership percentage — EcoR1 Capital Fund Qualified, L.P. 2.8% Percentage of the class reported.
Common shares outstanding 103,652,656 shares Outstanding as of July 27, 2026; denominator used for the reported percentages.
beneficial ownership regulatory
"Each reporting person also disclaims beneficial ownership"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared voting power 3,028,116"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared dispositive power 3,028,116"
pecuniary interest regulatory
"except to the extent of that person's pecuniary interest therein"
Rule 13d-3 regulatory
"beneficial owner, as defined in Rule 13d-3 under the Act"
Rule 13d-3 defines who is treated as the beneficial owner of a company’s shares for U.S. securities disclosure rules — essentially anyone who has the power to vote or direct how shares are voted, or the power to buy or sell them, even if they don’t hold the certificates. For investors this matters because crossing certain ownership thresholds triggers public filing and disclosure obligations and signals potential control or influence, much like having the keys to a car implies you can drive it even if it’s registered to someone else.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ORIC shares did each reporting person report owning?

EcoR1 Capital, LLC and Oleg Nodelman each reported beneficial ownership of 3,028,116 ORIC common shares, or 2.9%; EcoR1 Capital Fund Qualified, L.P. reported 2,885,435 shares, or 2.8%. Each reported shared voting and dispositive power over its stated amount.

What denominator was used for the ORIC ownership percentages?

The percentages were calculated using 103,652,656 ORIC common shares outstanding as of July 27, 2026.

How are EcoR1 Capital and Oleg Nodelman connected to Qualified Fund?

EcoR1 Capital, LLC is the general partner and investment adviser of investment funds including Qualified Fund. Oleg Nodelman is EcoR1 Capital’s control person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





68622P109

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 103,652,656 shares of Common Stock outstanding on July 27, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 103,652,656 shares of Common Stock outstanding on July 27, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 103,652,656 shares of Common Stock outstanding on July 27, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended June 30, 2026.


SCHEDULE 13G



EcoR1 Capital, LLC
Signature:/s/ Oleg Nodelman
Name/Title:Manager
Date:11/16/2026
Oleg Nodelman
Signature:/s/ Oleg Nodelman
Name/Title:Reporting person
Date:11/16/2026
EcoR1 Capital Fund Qualified, L.P.
Signature:/s/ Oleg Nodelman
Name/Title:Manager of the General Partner, EcoR1 Capital, LLC
Date:11/16/2026

Keep reading